Press Releases
Nov 14, 2022
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Nov. 14, 2022-- Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the three and nine months ended September 30, 2022 and provided an update on key initiatives. Business Update Tricida announced in October the top-line results from its
Nov 02, 2022
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Nov. 2, 2022-- Tricida, Inc. (NASDAQ: TCDA), announced today that the Board of Directors has authorized Tricida to initiate a review of strategic alternatives to maximize stakeholder value. To facilitate this review, Tricida has engaged Stifel and its
Oct 24, 2022
Webcast today at 8:00 am Eastern Time SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 24, 2022-- Tricida, Inc. (NASDAQ: TCDA) announced today the top-line results from its VALOR-CKD renal outcomes clinical trial, designed to evaluate veverimer’s ability to slow CKD progression in patients with
Oct 19, 2022
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 19, 2022-- Tricida, Inc. (Nasdaq: TCDA) announced today that it has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets.
Oct 03, 2022
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Oct. 3, 2022-- Tricida, Inc. (Nasdaq: TCDA) announced today that a late-breaking clinical trial abstract on the Phase 3, VALOR-CKD renal outcomes trial has been selected by the American Society of Nephrology (ASN) and the Kidney Week Education
Sep 06, 2022
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Sep. 6, 2022-- Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference . Tricida will provide a company overview, business update and progress on the company’s key initiatives.
Aug 08, 2022
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Aug. 8, 2022-- Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the three and six months ended June 30, 2022 and provided an update on key initiatives.
Aug 01, 2022
SOUTH SAN FRANCISCO, Calif. , Aug. 01, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2022 financial results after the close of market on Monday, August 8, 2022 . Tricida will host a webcast and conference call at 4:30 pm Eastern Time to
May 19, 2022
Expects to Announce Top-Line Results Early in the Fourth Quarter of 2022 SOUTH SAN FRANCISCO, Calif. , May 19, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) announced today that as anticipated it is stopping its VALOR-CKD renal outcomes trial early for administrative reasons pursuant to the
May 10, 2022
Webcast Today at 4:30 pm Eastern Time SOUTH SAN FRANCISCO, Calif. , May 10, 2022 (GLOBE NEWSWIRE) -- Tricida, Inc. (Nasdaq: TCDA) announced today financial results for the three months ended March 31, 2022 and provided an update on key initiatives. Business Update Tricida continued to execute on